MIRA Pharmaceuticals News

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez

Nov 27 16:18 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Nov 26 16:19 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner McNulty Brian Patrick

Aug 30 16:10 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji

Jun 21 16:32 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez

May 30 18:03 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez

May 22 17:45 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez

Mar 27 17:55 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji

Mar 27 17:55 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle

Mar 27 17:55 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen

Mar 27 17:55 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston

Mar 27 17:55 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul

Mar 27 17:55 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Shekhat Denil Nanji

Mar 22 19:03 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul

Mar 22 16:19 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director MacPherson Edward Clouston

Mar 22 16:18 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner McNulty Brian Patrick

Dec 27, 2023 00:00 ET

MIRA Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian McNulty, Individually and as Trustee of the Bay Shore Trust(31.01%),Bay Shore Trust(26.94%)

Dec 27, 2023 00:00 ET

MIRA Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian McNulty, Individually and as Trustee of the Bay Shore Trust(32.45%),Bay Shore Trust(27.66%)

Nov 20, 2023 16:18 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jerman Michael Allen

Nov 20, 2023 16:15 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust

Nov 17, 2023 17:09 ET